Overview

Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in Children

Status:
Withdrawn
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and effectiveness of Hydrocodone Bitartrate (HYD) tablets in children with moderate to severe pain requiring around-the-clock opioid analgesics.
Phase:
Phase 2
Details
Lead Sponsor:
Purdue Pharma LP
Treatments:
Hydrocodone